ProCE Banner Activity


ASCO 2022: Advances in CLL/SLL

Podcast Episodes

Listen as John M. Burke, MD and Amy Esposito, FNP-C discuss some of the latest key data that may impact clinical practice for patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) reported at the American Society of Clinical Oncology (ASCO) 2022 Annual Conference

Physician Assistants: maximum of 0.50 hours of AAPA Category 1 CME credits Registered Nurses: 0.50 Nursing contact hours, includes 0.50 hour of pharmacology credit

Released: June 30, 2022

Expiration: June 29, 2023

No longer available for credit.



John M. Burke

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado

Amy Esposito

Amy Esposito, FNP-C

Nurse Practitioner
Rocky Mountain Cancer Center
Aurora, Colorado


This activity is supported by an educational grant from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Provided by

ProCE Banner


Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Pharmacyclics LLC, an AbbVie Company

Target Audience

Oncology NPs, PAs and nurses

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Identify recent practice-changing data in the management of SLL and CLL

  • Describe strategies for management and monitoring of patients with SLL and CLL based on the most current efficacy and safety evidence


John M. Burke, MD: consultant: AbbVie, Adaptive Biotechnologies, AstraZeneca, Bayer, BeiGene, Bristol Myers Squibb, Epizyme, Kura, Kymera, Lilly, MorphoSys, Nurix, Roche/Genentech, Seagen, TG Therapeutics, Verastem; speaker: BeiGene, Seattle Genetics.

Amy Esposito, FNP-C, has no relevant financial relationships to disclose.

None of the members of the Planning Committee or PCE staff have any relevant financial relationships to disclose.

Instructions for Credit

Participants wishing to earn CE/CME credit must:

  1. Listen to the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete the post-test and evaluation form

Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of 100%.

The estimated time to complete this activity is 0.50 hours.

Release date: June 30, 2022
Expiration date: June 29, 2023





Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

Nursing contact hours: 0.50, which includes 0.50 hours of pharmacology credit

AAPA Credit Designation

Joint AccreditationPracticing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. Approval is valid until June 29, 2023. PAs should only claim credit commensurate with the extent of their participation.

PA course advisor: Jessica Garner, DMSc, PA-C, University of the Pacific, Sacramento, California

IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credits for learning and change.

Additional Information

Program Medium

This program has been made available online.